A detailed history of Pnc Financial Services Group, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,616 shares of CRMD stock, worth $17,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,616
Previous 408 296.08%
Holding current value
$17,372
Previous $1,000 1200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.64 - $8.23 $4,397 - $9,941
1,208 Added 296.08%
1,616 $13,000
Q1 2024

May 10, 2024

BUY
$2.94 - $4.24 $1,146 - $1,653
390 Added 2166.67%
408 $1,000
Q4 2023

Feb 09, 2024

BUY
$3.0 - $4.01 $54 - $72
18 New
18 $0

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $443M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.